ArticleJACC. Case reports2026
Delayed Cardiac Tamponade After Vein of Marshall Ethanol Infusion for Atrial Fibrillation Ablation.
Article in JACC. Case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Feasibility of pulsed field ablation in the coronary venous system using a linear multielectrode catheter: a preclinical study in a swine model.Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCardiac tamponade is a serious complication of atrial fibrillation (AF) ablation, usually periprocedural. Delayed cardiac tamponade (DCT) is a rare but life-threatening complication. CASE SUMMARY: A 75-year-old woman presented in shock 16 days after AF ablation including vein of Marshall ethanol infusion. Early postprocedural echocardiography showed no effusion. Pericardiocentesis drained 1,050 mL of hematic effusion with rapid stabilization. Anticoagulation was resumed at 48 hours. The patient remained well at 6-month follow-up. DISCUSSION: Most tamponades occur intraoperatively or immediately after the procedure; delayed presentations are uncommon. In the setting of vein of Marshall ethanol infusion, both mechanical injury and inflammatory processes may predispose to DCT. Normal early imaging does not exclude this complication, underscoring the need for vigilance and patient education.
conclusionsAwareness of DCT is essential, because patients may appear stable at discharge yet later present in shock. Clinicians should suspect tamponade in any postablation patient with unexplained deterioration, as prompt recognition and drainage can be lifesaving. TAKE-HOME MESSAGES: Delayed cardiac tamponade, although rare, may present days to weeks after AF ablation, even with normal early postprocedural imaging. Vigilance and patient education are critical, because prompt recognition and drainage of tamponade are lifesaving.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.